0 0 0 0 0 0 0 0
Thanks for submitting the form.
Stockreport

ISRG Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]

Intuitive Surgical, Inc. (ISRG)  More Company Research Source: Globe and Mail, The
Last intuitive surgical, inc. earnings: 4/16 04:05 pm Check Earnings Report
Chief Financial Officer — Jamie Samath Chief Medical Officer — Jamie Wong Senior Vice President, Strategy & Investor Relations — Daniel Connally TAKEAWAYS Total Procedures -- Increased 17% to 890,000, including 16% growth in da Vinci and 39% growth in Ion procedures. da Vinci Procedures (U.S.) -- Rose 14%, supported by 31% growth in after-hours procedures and a 4% increase in U.S. utilization, with da Vinci 5 utilization about 11% higher than Xi. da Vinci Procedures (Outside U.S.) -- Grew 19%, now representing 38% of total da Vinci volume, led by general surgery and gynecology; Asia growth lagged, with ongoing challenges in China and Japan. Ion Procedures -- Expanded 39% to 43,000 procedures, including clinical adoption reinforced by recent Mayo Clinic data showing a diagnostic yield of 79% and sensitivity of 85% for malignancy. Single Port (SP) Platform Procedures -- Increased 68%, driven by adoption in Korea, the U.S., and early-stage growth in Europe, Japan, and Ta [Read more]

IMPACT SNAPSHOT EVENT TIME: ISRG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

ISRG Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]

Intuitive Surgical, Inc.  (ISRG) 
Last intuitive surgical, inc. earnings: 4/16 04:05 pm Check Earnings Report
Chief Financial Officer — Jamie Samath Chief Medical Officer — Jamie Wong Senior Vice President, Strategy & Investor Relations — Daniel Connally TAKEAWAYS Total Procedures -- Increased 17% to 890,000, including 16% growth in da Vinci and 39% growth in Ion procedures. da Vinci Procedures (U.S.) -- Rose 14%, supported by 31% growth in after-hours procedures and a 4% increase in U.S. utilization, with da Vinci 5 utilization about 11% higher than Xi. da Vinci Procedures (Outside U.S.) -- Grew 19%, now representing 38% of total da Vinci volume, led by general surgery and gynecology; Asia growth lagged, with ongoing challenges in China and Japan. Ion Procedures -- Expanded 39% to 43,000 procedures, including clinical adoption reinforced by recent Mayo Clinic data showing a diagnostic yield of 79% and sensitivity of 85% for malignancy. Single Port (SP) Platform Procedures -- Increased 68%, driven by adoption in Korea, the U.S., and early-stage growth in Europe, Japan, and Ta [Read more]

IMPACT SNAPSHOT
EVENT TIME:
ISRG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS